MoneyWorks4Me

Hester Biosciences informs about newspaper clippings

09 Aug 2023 Evaluate

In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has submitted a copy of the published extract of consolidated unaudited financial results for the quarter ended 30 June 2023 along with information on standalone financial results. The same was published on Wednesday, 9 August 2023 in the Ahmedabad edition of Financial Express (English) and Financial Express (Gujarati).

The above information is a part of company’s filings submitted to BSE. 

Hester Biosciences Share Price

2452.85 -29.95 (-1.21%)
12-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.00
Dr. Reddys Labs. 1198.95
Cipla 1461.55
Lupin 2264.70
Zydus Lifesciences 1204.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: